Jeanne Languepin
Limoges, 87000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat-Soluble Vitamin Status in 2 to 5 Year-Old Children Using a Cystic Fibrosis-Specific Multivitamin Formulation.
Journal: Children (Basel, Switzerland)
Published: May 24, 2026
Recognizing Arthralgia as a Potential Adverse Effect of CFTR Modulators: A Case Report.
Journal: Clinical therapeutics
Published: September 18, 2025
Impact of a Cystic Fibrosis Specific Multivitamin Formulation on Fat-Soluble Vitamin Status and Treatment Satisfaction in Young Children.
Journal: Children (Basel, Switzerland)
Published: June 17, 2025
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis.
Journal: Clinical and translational science
Published: March 07, 2025
The validated French CFAbd-Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor.
Journal: Journal of pediatric gastroenterology and nutrition
Published: January 09, 2025
Dietary intake remains unchanged while nutritional status improves in children and adults with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: December 05, 2024
Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring.
Journal: Therapeutic drug monitoring
Published: June 03, 2024
Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.
Journal: The European respiratory journal
Published: September 03, 2023
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.
Journal: The European respiratory journal
Published: January 18, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.
Journal: The European respiratory journal
Published: December 20, 2022
Last Updated: 09/26/2026